EPISODE · Dec 4, 2025 · 21 MIN
Kidney Damage Biomarkers - Ep 173
from ACCP JOURNALS · host ACCP JOURNALS
The mortality and economic burden of drug-induced acute kidney injury are substantial, emphasizing the need for prevention and optimal treatment. Dr. Sandra Kane-Gill provides perspective on novel kidney biomarkers and how they offer a missing piece of the assessment for early detection and management of drug-induced acute kidney injury. Read the full manuscript at: https://accpjournals.onlinelibrary.wiley.com/doi/full/10.1002/phar.70071
What this episode covers
The mortality and economic burden of drug-induced acute kidney injury are substantial, emphasizing the need for prevention and optimal treatment. Dr. Sandra Kane-Gill provides perspective on novel kidney biomarkers and how they offer a missing piece of the assessment for early detection and management of drug-induced acute kidney injury. Read the full manuscript at: https://accpjournals.onlinelibrary.wiley.com/doi/full/10.1002/phar.70071
NOW PLAYING
Kidney Damage Biomarkers - Ep 173
No transcript for this episode yet
Similar Episodes
Jun 10, 2026 ·64m
Jun 3, 2026 ·30m
Jun 3, 2026 ·29m
May 29, 2026 ·30m